Urinary bisphenol a concentration and thyroid function in Chinese adults

Epidemiology

Volumn 24, Issue 2, 2013, Pages 295-302

  Wang, Tiange ^a,b   Lu, Jieli ^a,b   Xu, Min ^a,b   Xu, Yu ^a,b   Li, Mian ^a,b   Liu, Yu ^a,b   Tian, Xiaoguang ^a,b   Chen, Yuhong ^a,b   Dai, Meng ^a,b   Wang, Weiqing ^a,b   Lai, Shenghan ^a,c   Bi, Yufang ^a,b   Ning, Guang ^a,b  

^a BEIJING HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOLISM; ARTICLE; BODY MASS; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; CREATININE URINE LEVEL; EDUCATIONAL STATUS; FEMALE; FREE LIOTHYRONINE INDEX; HORMONE URINE LEVEL; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SUBCLINICAL HYPERTHYROIDISM; THYROID FUNCTION; URINALYSIS;

AGED; BENZHYDRYL COMPOUNDS; CHINA; ENVIRONMENTAL EXPOSURE; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOLS; THYROID GLAND; THYROTROPIN; TRIIODOTHYRONINE;

EID: 84873405936     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e318280e02f     Document Type: Article

References (32)

1. L ewis JB, Rueggeberg FA, Lapp CA, Ergle JW, Schuster GS. Identification and characterization of estrogen-like components in commercial resin- based dental restorative materials. Clin Oral Investig. 1999;3:107-113.
2. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24:139-177.
3. C alafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116:39-44.
4. L ang IA, Galloway TS, Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 2008;300:1303-1310.
5. N ing G, Bi Y, Wang T, et al. Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults: a crosssectional analysis. Ann Intern Med. 2011;155:368-374.
6. Wang T, Li M, Chen B, et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab. 2012;97:E223-E227.
7. L i M, Bi Y, Qi L, et al. Exposure to bisphenol A is associated with lowgrade albuminuria in Chinese adults. Kidney Int. 2012;81:1131-1139.
8. Zhao HY, Bi YF, Ma LY, et al. The effects of bisphenol A (BPA) exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women. Clin Biochem. 2012;45:1602-1606.
9. Moriyama K, Tagami T, Akamizu T, et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab. 2002;87:5185-5190.
10. Kaneko M, Okada R, Yamamoto K, et al. Bisphenol A acts differently from and independently of thyroid hormone in suppressing thyrotropin release from the bullfrog pituitary. Gen Comp Endocrinol. 2008;155:574-580.
11. Meeker JD, Calafat AM, Hauser R. Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic. Environ Sci Technol. 2010;44:1458-1463.
12. Meeker JD, Ferguson KK. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environ Health Perspect. 2011;119:1396-1402.
13. G ammage MD, Parle JV, Holder RL, et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med. 2007;167:928-934.
14. He Y, Miao M, Herrinton LJ, et al. Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels. Environ Res. 2009;109:629-633.
15. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrinedisrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293-342.
16. Miller MD, Crofton KM, Rice DC, Zoeller RT . Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect. 2009;117:1033-1041.
17. Zoeller RT, Bansal R, Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology. 2005;146:607-612.
18. Xu X, Liu Y, Sadamatsu M, et al. Perinatal bisphenol A affects the behavior and SRC-1 expression of male pups but does not influence on the thyroid hormone receptors and its responsive gene. Neurosci Res. 2007;58:149-155.
19. Kobayashi K, Miyagawa M, Wang RS, Suda M, Sekiguchi S, Honma T. Effects of in utero and lactational exposure to bisphenol A on thyroid status in F1 rat offspring. Ind Health. 2005;43:685-690.
20. T eeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol Sci. 2005;85:823-838.
21. Melzer D, Galloway T. Bisphenol A and adult disease: making sense of fragmentary data and competing inferences. Ann Intern Med. 2011;155: 392-394.
22. Zoeller RT . Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals? Mol Cell Endocrinol. 2005;242:10-15.
23. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE. 2010;5:e8673.
24. Melzer D, Osborne NJ, Henley WE, et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation. 2012;125:1482-1490.
25. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23:38-89.
26. Heeringa J, Hoogendoorn EH, van der Deure WM, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med. 2008;168:2219-2224.
27. I nada M, Kasagi K, Kurata S, et al. Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man. J Clin Invest. 1975;55:1337-1348.
28. L arsen PR, Frumess RD. Comparison of the biological effects of thyroxine and triiodothyronine in the rat. Endocrinology. 1977;100: 980-988.
29. Baloch Z, Carayon P, Conte-Devolx B, et al; guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13:3-126.
30. L ee JS, Buzková P, Fink HA, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010;170: 1876-1883.
31. Soldin SJ, Cheng LL, Lam LY, Werner A, Le AD, Soldin OP. Comparison of FT4 with log TSH on the Abbott Architect ci8200: pediatric reference intervals for free thyroxine and thyroid-stimulating hormone. Clin Chim Acta. 2010;411:250-252.
32. Soldin OP, Soldin SJ. Thyroid hormone testing by tandem mass spectrometry. Clin Biochem. 2011;44:89-94.